Recall of original serologic response after challenge with homologous and heterologous Chlamydia trachomatis serovars

被引:7
|
作者
Zhao, QX
Lammel, CJ
Lindquist, EA
Stephens, RS
机构
[1] UNIV CALIF BERKELEY,SCH PUBL HLTH,PROGRAM INFECT DIS,BERKELEY,CA 94720
[2] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,FRANCIS I PROCTOR FDN,SAN FRANCISCO,CA 94143
来源
JOURNAL OF INFECTIOUS DISEASES | 1996年 / 173卷 / 03期
关键词
D O I
10.1093/infdis/173.3.609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia trachomatis serovar-specific major outer membrane protein (MOMP) antigens are important targets of immune neutralization in vitro, and natural immunity to infection is associated with serovar specificity. Reinfection, often by different serovars, plays an essential role in chlamydial disease pathogenesis. By use of a murine model, the anamnestic serologic response was characterized following priming and challenge inoculations using 6 different serovars. The serologic response was evaluated using synthetic peptides representing MOMP variant segments (VS) 1, 2, 3, and 4 antigenic regions for each of the 6 serovars. One year after a single priming inoculation, challenge with the same serovar resulted in serologic responses to homologous VS1 peptides. After challenge with a different serovar, anti-VS1 serologic responses were often elicited with specificity to both the priming serovar and the challenge serovar, The recall of serologic response to the original serovar was typically dependent upon the antigenic relationship of the 2 serovars.
引用
收藏
页码:609 / 618
页数:10
相关论文
共 40 条
  • [31] LONG-LASTING PROTECTION OF SHEEP AGAINST BLUETONGUE CHALLENGE AFTER VACCINATION WITH VIRUS-LIKE PARTICLES - EVIDENCE FOR HOMOLOGOUS AND PARTIAL HETEROLOGOUS PROTECTION
    ROY, P
    BISHOP, DHL
    LEBLOIS, H
    ERASMUS, BJ
    VACCINE, 1994, 12 (09) : 805 - 811
  • [32] Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge
    Pal, S
    Davis, HL
    Peterson, EM
    de la Maza, LM
    INFECTION AND IMMUNITY, 2002, 70 (09) : 4812 - 4817
  • [33] Immune response does not prevent homologous Porcine epidemic diarrhoea virus reinfection five months after the initial challenge
    Diaz, Ivan
    Pujols, Joan
    Cano, Esmeralda
    Cortey, Marti
    Navarro, Nuria
    Vidal, Anna
    Mateu, Enric
    Martin, Marga
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (03) : 997 - 1009
  • [34] Antibody Response to Booster mRNA COVID-19 Vaccine After Standard Doses of Various Homologous and Heterologous Vaccines in Kidney Transplant Recipients
    Han, Ahram
    Min, Sangil
    Jo, Eun-Ah
    Woo, Hye Young
    Cho, Ara
    Lee, Hajeong
    Kim, Yong Chul
    Kang, Hee Kyung
    Ahn, Yo Han
    Song, Eun Young
    Ha, Jongwon
    TRANSPLANTATION, 2022, 106 (09) : S10 - S10
  • [35] Antibody response after two doses of homologous or heterologous SARS-CoV-2 vaccines in healthcare workers at health promotion centers: A prospective observational study
    Nah, Eun-Hee
    Cho, Seon
    Park, Hyeran
    Kim, Suyoung
    Noh, Dongwon
    Kwon, Eunjoo
    Cho, Han-Ik
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4719 - 4726
  • [36] Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients A Randomized Clinical Trial
    Reindl-Schwaighofer, Roman
    Heinzel, Andreas
    Mayrdorfer, Manuel
    Jabbour, Rhea
    Hofbauer, Thomas M.
    Merrelaar, Anne
    Eder, Michael
    Regele, Florina
    Doberer, Konstantin
    Spechtl, Paul
    Aschauer, Constantin
    Koblischke, Maximilian
    Paschen, Christopher
    Eskandary, Farsad
    Hu, Karin
    Ohler, Barbara
    Bhandal, Arshdeep
    Kleibenbock, Sabine
    Jagoditsch, Rahel, I
    Reiskopf, Bianca
    Heger, Florian
    Bond, Gregor
    Bohmig, Georg A.
    Strassl, Robert
    Weseslindtner, Lukas
    Indra, Alexander
    Aberle, Judith H.
    Binder, Michael
    Oberbauer, Rainer
    JAMA INTERNAL MEDICINE, 2022, 182 (02) : 165 - 171
  • [37] Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
    Shaw, Robert H.
    Liu, Xinxue
    Stuart, Arabella S., V
    Greenland, Melanie
    Aley, Parvinder K.
    Andrews, Nick J.
    Cameron, J. Claire
    Charlton, Sue
    Clutterbuck, Elizabeth A.
    Collins, Andrea M.
    Dejnirattisai, Wanwisa
    Dinesh, Tanya
    Faust, Saul N.
    Ferreira, Daniela M.
    Finn, Adam
    Green, Christopher A.
    Hallis, Bassam
    Heath, Paul T.
    Hill, Helen
    Lambe, Teresa
    Lazarus, Rajeka
    Libri, Vincenzo
    Long, Fei
    Mujadidi, Yama F.
    Plested, Emma L.
    Morey, Ella R.
    Provstgaard-Morys, Samuel
    Ramasamy, Maheshi N.
    Ramsay, Mary
    Read, Robert C.
    Robinson, Hannah
    Screaton, Gavin R.
    Singh, Nisha
    Turner, David P. J.
    Turner, Paul J.
    Vichos, Iason
    Walker, Laura L.
    White, Rachel
    Nguyen-Van-Tam, Jonathan S.
    Snape, Matthew D.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (11): : 1049 - 1060
  • [38] Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection
    Ferrari, Luca
    Martelli, Paolo
    Saleri, Roberta
    De Angelis, Elena
    Cavalli, Valeria
    Bresaola, Marcello
    Benetti, Michele
    Borghetti, Paolo
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2013, 151 (3-4) : 193 - 206
  • [39] Low doses of AF03-adjuvanted pandemic influenza A/H5N1 and A/H1N1 vaccines protect ferrets against infection after homologous and heterologous viral challenge
    Piras, Fabienne
    Caillet, Catherine
    Bernard, Marie-Clotilde
    Vogel, Frederick R.
    Kusters, Inca
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 : 360 - 363
  • [40] Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407
    Chakraborty, Subhra
    Harro, Clayton
    DeNearing, Barbara
    Ram, Malathi
    Feller, Andrea
    Cage, Alicia
    Bauers, Nicole
    Bourgeois, A. Louis
    Walker, Richard
    Sack, David A.
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (01) : 55 - 64